Frazier Lifesciences Acquisition Corp

Frazier Lifesciences Acquisition Corp, trading under the ticker FLAC, is a special purpose acquisition company sponsored by Frazier Healthcare Partners, a dedicated life sciences and healthcare-focused investment firm. The SPAC completed its initial public offering in 2021 and targeted acquisition opportunities within the life sciences, biopharmaceutical, and medical technology sectors. A Form 10-Q filed with the SEC on May 12, 2022, under accession number 0001193125-22-147717, reflects the company's continued operation as a blank-check vehicle during that reporting period. Frazier Healthcare Partners brings deep sector expertise across drug development, diagnostics, and medical devices to its SPAC sponsorship. Sign up at SpacDesk for full filing history, deal timelines, and sponsor profiles on FLAC and hundreds of other SPACs.